TABLE 1.
Source | Treatment | TNF-α concn (pg/ml)a
|
P | |
---|---|---|---|---|
HP | LP | |||
Serumb | None | 162.2 ± 23.9 | 395.8 ± 45.3 | <0.001 |
Intravenous PPD injection | 2,409.5 ± 404.6 | 8,802.5 ± 872.5 | <0.001 | |
Macrophagec | PPD | 3,188.2 ± 426.6 | 1,238.8 ± 148.1 | <0.01 |
H37Rv infection (2 days) | 1,322.4 ± 242.8 | 781.2 ± 182.5 | <0.01 | |
H37Rv infection (4 days) | 1,069.5 ± 248.3 | 502.7 ± 99.6 | <0.001 |
Mean ± standard error of the mean for four to six guinea pigs per treatment.
Sera were separated from M. tuberculosis H37Ra-vaccinated guinea pigs with or without an intravenous injection of 1 mg of PPD/kg of body weight 2 h prior to euthanization.
Peritoneal macrophages were stimulated with PPD at 15 μg/ml for 24 h or infected with M. tuberculosis H37Rv for 2 and 4 days. Cell-free supernatants were collected and measured for TNF-α bioactivity.